维普期刊资源整合服务平台（V6.5）

39篇 您的检索式：作者名="Rzonca"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Bone is a target for the anfidia- betic compound rosiglitazone显示文摘	Rzonca SO Suva LJ Gaddy D	2004	Endocrinology2004，1，：	1
2	Rosiglitazone induces decreases in bone mass and strength that are reminiscent of aged bone 显示文摘	Lzarenko OP Rzonca SO Hague WR	2007	Endocrinology2007，6，：	1
3	Bone is a target for the an-tidiabetic compound msiglitazone显示文摘	Rzonca SO Suva LJ Gaddy D	2004	Endocrinology2004，145，1：	1
4	Rosiglitazone induces decreases in bone mass and strength that are reminiscent of aged bone显示文摘	Lazarenko P O Rzonca S O Hogue W R Swain F L Suva L J Lecka-Czernik B	2007	Endocrinology2007，148，：	1
5	Bone is a target for the antidiabetic compound rosiglitazone显示文摘	Rzonca S O Suva L J Gaddy D	2004	Endocrinology2004，145，1：	1
6	Rosiglitazone induces decreases in bone mass and strength that are reminiscent of aged bone 显示文摘	Lazarenko OP Rzonca SO Hogue WR	2007	Endocrinology2007，148，6：	1
7	Bone is a target for the antidiabetic compound rosiglitazone显示文摘	Rzonca SO Suva LJ Gaddy D		0，，01：	1
8	Rosiglitazone induces decreases in bone mass and strength that are reminiscent of aged bone显示文摘	Lazarenko OP Rzonca SO Hogue WR Swain FL Suva LJ Lecka-Czernik B		0，，：	1
9	Bone is a target for the antidiabetic compound rosiglitazone显示文摘	Rzonca SO Suva LJ Caddy D	2004	Endocrinology2004，145，1：	1
10	Rosiglitazone induces decreases in bone mass and strength that are reminiscent of aged bone显示文摘	Lazarenko OP Rzonca SO Hogue WR	2007	Endocrinology2007，148，：	1
11	Bone is a target for the antidiabetic compound rosiglitazone显示文摘	Rzonca SO Suva LJ Gaddy D	2004	Endocrinology2004，145，：	1
12	Rosigtitazoneinduces Decreases in bone mass and strength that arc reminiscent of aged bone 显示文摘	Lazaretxko OP Rzonca SO Hogue WR	2007	Endocrinology2007，148，6：	1
13	Netoglitazone is a PPAR-'y ligand with selective effects on bone and fat显示文摘	Lazarenko OP Rzonca SO Suva LJ	2006	Bone2006，38，：	1
14	Bone is a target for the antidiabetic compound rosi ghtazone 显示文摘	Rzonca SO Suva LJ Gaddy D	2004	Endocrinol- ogy2004，145，：	1
15	Bone is a target for the antidiabetic compound rosiglitazone 显示文摘	Rzonca SO Suva LJ Gaddy D	2004	Endocrinology2004，145，1：	1
16	Bone is a target for the antidiabetic compound rosiglitazone 显示文摘	Rzonca SO Suva LJ Gaddy D	2004	Endocrinology2004，145，1：	1
17	Bone is a target for the antidiabetic compound rosiglitazone显示文摘	Rzonca SO Suva LJ Gaddy D	2004	Endocrinology2004，145，1：	1
18	Rosigiitazone in- duces decreases in bone mass and strength that are reminiscent of aged bone 显示文摘	Lasarenko OP Rzonca SO Hogue WR	2007	Endocrinology2007，148，6：	1
19	Netoglitazone is a PPAR-gamma ligand with selective effects on bone and fat显示文摘	Lazarenko O P Rzonca S O Suva L J	2006	Bone2006，38，1：	1
20	Bone is a target for the antidiabetic compound rosiglitazone显示文摘	Rzonca SO Suva LJ Caddy D et a1	2004	Endocrinology2004，145，1：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示